- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about MCK
Recent news which mentions MCK
10 Health Care Stocks Whale Activity In Today's Session
April 08, 2022
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
April 07, 2022
From Benzinga
From Benzinga
Johnson & Johnson Sees A Strong Move: Is It Ready For A Breakout?
February 25, 2022
From Benzinga
Drug Distributors, JNJ Agree To Settle $26B Opioid Lawsuits
February 25, 2022
From Benzinga
10 Biggest Price Target Changes For Tuesday
February 08, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 4, 2022
February 04, 2022
From Benzinga
2 Lesser-Known Stocks That Could Outperform Tesla In 2022
February 04, 2022
From Benzinga
21 Stocks Moving in Thursday's Pre-Market Session
February 03, 2022
From Benzinga
McKesson Q3 Earnings Beat Street View, Raises FY22 Outlook Boosted By COVID-19 Vaccine Demand
February 03, 2022
Tickers
MCK
From Benzinga
A Peek Into The Markets: Nasdaq Futures Tumble Following Downbeat Earnings From Meta
February 03, 2022
From Benzinga
7 Stocks To Watch For February 3, 2022
February 03, 2022
From Benzinga
Johnson & Johnson, Distributors Reach $590M Opioid Settlement For Tribe Claims: Report
February 02, 2022
From Benzinga
Earnings Scheduled For February 2, 2022
February 02, 2022
From Benzinga
BioCorRx Aims To Help Combat Opioid Crisis With Implantable Naltrexone Drug Candidate BICX104
January 24, 2022
From Benzinga
7 Low Labor-Cost Stocks to Buy for Solid Margins in 2022
January 21, 2022
From InvestorPlace
Even the beleaguered tech sector has winners from rising inflation. Here are some of Credit Suisse’s favorites.
January 20, 2022
From MarketWatch
3 New ETFs to Put on Your January Buy List
January 18, 2022
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022
January 07, 2022
From Benzinga
Teva Suffers Loss In New York's Opioid Trial
January 03, 2022
From Benzinga
10 Biggest Price Target Changes For Thursday
December 09, 2021
From Benzinga
Walgreens To Explore Options For UK's Boots Pharmacy Chain: Sky News
December 06, 2021
From Benzinga
McKesson, Cardinal Health, AmerisourceBergen Face $95B Opioid Trial In Washington: Reuters
November 15, 2021
From Benzinga
2 Moonshots That Insiders Are Buying… and 3 They’re Not
November 09, 2021
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.